AstraZeneca Posts Revenue, Profit Growth on Strong Cancer-Drug Sales

Date:




The U.K. drugmaker reported net profit of $3.12 billion for the third quarter, up from $2.535 billion for the same period last year.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related